PLSE

NASDAQStock

Pulse Biosciences, Inc.

$21.67+0.37 (+1.74%)

52-Week Range

$12.66

$25.46

Key Stats

Market Cap

1.5B

P/E Ratio

—

Dividend Yield

—

Beta

1.82

Volume

319.7K

Avg Volume

343.6K

Performance

-8.97%

+50.74%

+35.32%

YTD

+59.07%

+25.96%

+574.05%

-31.62%

Price Chart

ETF Exposure

PLSE is held by 56 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
VTWV	Vanguard Russell 2000 Value ETF	0.00%	853	$2K	$1.00B	0.06%
VUN.TO	Vanguard U.S. Total Market Index ETF	0.00%	3,105	$58K	$15.33B	0.17%
VUS.TO	Vanguard U.S. Total Market Index ETF (CAD-hedged)	0.00%	267	$5K	$1.29B	0.17%
XEQT.TO	iShares Core Equity ETF Portfolio	0.00%	37,736	$59K	$14.63B	0.20%
XUU.TO	iShares Core S&P U.S. Total Market Index ETF	0.00%	37,736	$18K	$3.91B	0.07%
ZPRV.DE	State Street SPDR MSCI USA Small Cap Value Weighted UCITS ETF	0.00%	65	$1K	$757.5M	0.30%

PreviousPage 2 of 2

About PLSE ETF Exposure

Pulse Biosciences, Inc. (PLSE) is held by 56 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 1.5B, PLSE is a widely held institutional stock. The stock currently trades at $21.67. Investors can gain exposure to PLSE through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold PLSE, sorted by portfolio weight.